Amlodipine/benazepril

From Wikipedia, the free encyclopedia - View original article

Amlodipine/benazepril
Amlodipine.svg
Benazepril.svg
Combination of
AmlodipineCalcium channel blocker
BenazeprilACE inhibitor
Clinical data
Pregnancy cat.
Legal status
RoutesOral
Identifiers
ATC codeNone
PubChemCID 5746247
ChemSpider4676979 YesY
 YesY (what is this?)  (verify)
 
Jump to: navigation, search
Amlodipine/benazepril
Amlodipine.svg
Benazepril.svg
Combination of
AmlodipineCalcium channel blocker
BenazeprilACE inhibitor
Clinical data
Pregnancy cat.
Legal status
RoutesOral
Identifiers
ATC codeNone
PubChemCID 5746247
ChemSpider4676979 YesY
 YesY (what is this?)  (verify)

Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva and Sandoz, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besilate) with an angiotensin converting enzyme inhibitor (benazepril).[1] This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.[2][3]

See also[edit]

References[edit]

External links[edit]